On a daily basis, physicians from all disciplines, surgeons, medical and radiation oncologists, primary care physicians, pathologists and radiologists come together with research and support staffs to discuss patient cases for treatment planning and follow-up in Tumor Board Forums. The seven multidisciplinary Tumor Board programs focus on: Breast, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Hematological, Neurological, and Thoracic cases. The Oakwood Center for Cancer Care holds weekly tumor board conferences.
The multidisciplinary breast team is directed by physician leader Majd Aburabia, MD, breast surgeon. Unique to the Oakwood Breast Community Program is the availability of genetic education and testing. The cytogenetic team, under Julie Zenger-Hain, PhD, is available to women and their families to help determine this breast cancer risk.
The multidisciplinary gastrointestinal team is led by program leader Neelam Kumar, MD, pathologist, and associate program leaders, Fuad Turfah, MD, surgeon, and Renu Pandit, MD, medical oncologist. The affiliation with the Community Clinical Oncology Program (CCOP) provides an expanded opportunity to offer state-of-the-art clinical trials to the patient with bowel cancers.
Richard Sarle, MD, urologist and program leader, along with associate program leader Oscar Signori, MD, medical oncologist, have worked to provide a high-tech component to the genitourinary team. Screening provides early detection for prostate cancer. Urologists and radiation oncologists use Brachytherapy to implant radioactive seeds directly into the prostate gland to treat early tumors. Treatment options focus on organ preservation and nerve sparing radical surgeries. Combined therapies with surgery, radiation oncology and chemotherapy are approaches often used.
Michael Hicks, MD, works closely with the Ob/Gyn medical education program, focusing on combined therapies while working closely with Ob/Gyn primary care physicians. A very strong interaction with Radiation Oncologists, Choon K. Lee, MD, and Jung H. Chang, MD, gives the Gynecologic Oncology Tumor Boards true multidisciplinary decision making character.
Head and Neck
Lascelles Pinnock, MD, otolaryngologist and program leader, and Oscar Signori, MD, medical oncologist and associate program leader of the Head and Neck program, work closely with many specialties to assure a multidisciplinary approach to the care of head and neck cancer patients. The program cooperates with the participation of all related disciplines including radiation oncology, medical oncology, oral surgery, dentistry, speech pathology, nutrition and tracheostomy care.
Lyle Victor, MD, pulmonologist, along with associate program leaders Shanti Thomas, MD, medical oncologist, and thoracic surgeons, John Hilu, MD, and M. Salik Jahania, MD, work closely with team members, which include thoracic surgeons and radiation oncologists, to assure quality patient care. The program uses high-dose (rate) brachytherapy for intra-bronchial lesions as part of the brachytherapy program in the Department of Radiation Oncology.
George Hnatiuk, MD, internal medicine and hematology, along with associate program leader Parvez Khan, MD, medical oncologist, work closely with team members which include all disciplines to assure quality patient care.
The program leaders will facilitate the implementation of a leukemia and lymphoma program at Oakwood, supporting the private practitioners in the care of inpatients and support the program through monthly meetings and tumor boards.